P...Who would be making the deal? Professor Masters who was...

P...Who would be making the deal? Professor Masters who was awarded the exclusive license hopefully with royalties paid to Alterity. I thought the good Doctor Masters necessarily needed to conduct additional studies with PBT2 that, with positive results, could result in regulatory approvals without the need for Phase 3 clinical trials? Maybe he has or has not done so. As you pointed out, it's been 3 years! I also vaguely recall that he has done some testing in the last 2-3 tears with a very promising Japanese biotech drug to treat antibiotic resistance to bacterial infections. Hopefully, I am wrong about this, but it might explain why there has been no update/news from Masters which is very concerning if not aggravating.